Low levels of mesothelin expression in gastric cancer exhibited a notable correlation with both improved overall survival (OS) (p = .051) (Figure 1B, left panel) and disease‐free survival (DFS) (p = .067) (Figure S1C). This evidence concerns the gene MSLN and gastric cancer.